Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCommunisis PLC Regulatory News (CMS)

  • There is currently no data for CMS

Form 8.3 - Communisis plc

7 Nov 2018 16:06

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: UBAM Variable Capital Investment Company Luxembourg (UBAM SICAV)

Manco : UBP Asset Management (Europe) SA

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

UBAM Europe Small Cap Equity (sub-fund of UBAM SICAV)
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Communisis plc

ISIN: GB0006683238

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: NA
(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

06/11/2018 (in addition the UBAM has dealt on previous dates during the offer period as attached at the end of the form).
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

N0

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: 25p Ordinary

Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: 2,125,397 1.01
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

TOTAL:

2,125,397 1.01

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security Purchase/sale Number of securities Price per unit
25p Ordinary Sale 5661 70.9p

(b) Cash-settled derivative transactions

Class of relevant security Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities Price per unit
- - - - -

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit
- - - - - - - -

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit
- - - - -

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)
-

-

- -

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 6/11/2018
Contact name: Pierre Berger
Telephone number*: 41 58 819 2893

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Previously undisclosed trades:

Purchases and sales

Date of dealing Class of relevant security Purchase/sale Number of securities Price per unit
05/11/2018 25p Ordinary Sale 44,877 70.9
02/11/2018 25p Ordinary Sale 113,747 70.9
01/11/2018 25p Ordinary Sale 127,878 70.9
31/10/2018 25p Ordinary Sale 142,312 70.9

View source version on businesswire.com: https://www.businesswire.com/news/home/20181107005654/en/

Copyright Business Wire 2018

Date   Source Headline
3rd Aug 20177:00 amRNSCommunisis plc Interim Results
20th Jul 20177:00 amRNSDirector Declaration
30th Jun 20172:19 pmRNSTotal Voting Rights and Share Capital
25th May 20177:05 amRNSExternal Directorship
11th May 20173:19 pmRNSResult of AGM
28th Apr 201712:34 pmRNSTotal Voting Rights
6th Apr 20172:03 pmRNSMailing of Annual Reports and Accounts
4th Apr 20174:20 pmRNSBlock Listing Six Monthly Return
10th Mar 20172:44 pmRNSDirector/PDMR Shareholding
10th Mar 201712:22 pmRNSHolding(s) in Company
9th Mar 20173:27 pmRNSDirector/PDMR Shareholding
9th Mar 20177:00 amRNSPreliminary Results
10th Feb 201712:45 pmRNSHolding(s) in Company
8th Feb 20177:00 amRNSAppointment of Chairman Designate
3rd Feb 201712:54 pmRNSHolding(s) in Company
20th Jan 201710:53 amRNSHolding(s) in Company
19th Jan 20177:00 amRNSTrading Update
15th Dec 20167:00 amRNSSignificant contract win with HMRC
14th Dec 201611:14 amRNSHolding(s) in Company
12th Dec 201610:03 amRNSHolding(s) in Company
7th Dec 20163:14 pmRNSConfirmation of Reduction of Capital Exercise
24th Nov 201612:23 pmRNSHolding(s) in Company
21st Nov 20161:23 pmRNSDirector/PDMR Shareholding
17th Nov 20163:13 pmRNSBlocklisting Six Monthly Return
9th Nov 201611:18 amRNSResult of General Meeting
20th Oct 20161:00 pmRNSNotice of General Meeting
3rd Oct 20162:58 pmRNSTotal Voting Rights and Share Capital
25th Aug 20163:07 pmRNSMailing of Interim Report
8th Aug 201612:29 pmRNSHolding(s) in Company
4th Aug 20167:00 amRNSInterim Results
12th Jul 20168:53 amRNSHolding(s) in Company
1st Jul 201610:15 amRNSTotal Voting Rights and Share Capital
9th Jun 20167:00 amRNSFurther re: 1 February 2016
8th Jun 20161:41 pmRNSHolding(s) in Company
27th May 20164:18 pmRNSTotal Voting Rights and Share Capital
12th May 20162:40 pmRNSResult of AGM
29th Apr 20164:51 pmRNSTotal Voting Rights and Share Capital
28th Apr 20165:15 pmRNSNotification of transactions of directors
13th Apr 20165:35 pmRNSNotification of Transactions of Directors
13th Apr 20164:06 pmRNSHolding(s) in Company
12th Apr 20164:35 pmRNSNotification of Transactions of Directors
8th Apr 20162:38 pmRNSNotification of Transactions of Directors
5th Apr 20162:34 pmRNSHolding(s) in Company
1st Apr 20164:31 pmRNSBlocklisting Six Monthly Return
1st Apr 201611:35 amRNSMailing of Annual Report and Accounts
31st Mar 20169:00 amRNSTotal Voting Rights and Share Capital
18th Mar 20164:27 pmRNSDirector/PDMR Shareholding
14th Mar 201611:17 amRNSHolding(s) in Company
10th Mar 20162:08 pmRNSDirector/PDMR Shareholding
10th Mar 20169:01 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.